Partly. Several meta-analyses of randomized trials found zinc supplements lowered CRP, a blood marker of inflammation. But many trials were small and uneven, and many tested people with kidney disease or diabetes. Results for other markers were mixed, and too much zinc can block copper.
What zinc is, and why people think it calms inflammation
Zinc is a mineral your body needs every day. It can't store much of it, so you need a steady supply from food. Most of the zinc in your body sits in your muscles and bones.
Researchers have long described zinc as having anti-inflammatory and antioxidant roles. To test that idea in people, they give zinc pills or a dummy pill and then measure inflammation markers in the blood.
The marker most trials checked is CRP (C-reactive protein). Your liver makes more of it when there is inflammation in the body. Two others are IL-6 and TNF-alpha, signaling proteins that immune cells use to call for more inflammation.
Does zinc lower CRP?
In trials, mostly yes. The first big pooled look came in 2018. A meta-analysis, which combines the results of many studies, found 8 randomized trials of zinc and CRP. Zinc lowered CRP by about 1.68 mg/L on average.
In the 2018 review, low-quality studies showed bigger CRP drops than the overall result.From a 2018 meta-analysis in Eur J Pharmacol
Later reviews cast a wider net and found the same direction. A 2021 meta-analysis of 21 randomized trials with 1,321 adults found zinc lowered CRP by 0.92 mg/L. A 2022 review of 35 randomized trials with 1,995 people found lower CRP and lower hs-CRP, the more sensitive version of the test. Another 2021 review screened 2,258 papers and found lower CRP in adults across 22 comparisons. And a 2023 review of 75 studies on heart risk factors found zinc lowered CRP, IL-6 and TNF-alpha.
Four different teams, searching the research at different times and counting trials in different ways, all landed on the same direction for CRP. So why not call it settled?
Who was in those trials
Look at who took the pills, and a pattern shows up: many of the people in these trials were already living with a long-term illness that their doctors were treating.
In 15 randomized trials of people on dialysis for kidney failure, zinc lowered CRP and raised blood zinc. In the 2018 review, people with kidney problems saw CRP fall by 7.43 mg/L, far more than anyone else. A 2026 meta-analysis of 18 trials with 1,023 people with diabetes or prediabetes also found lower CRP, along with better insulin numbers.
Diabetes comes with a heavier inflammatory load, so there is more room for a marker to fall. A healthy adult adding zinc on top of a normal diet is a very different case. None of our sources tested that question well.
The numbers that make us careful
Three details kept our grade at Emerging.
First, the trials disagree with each other a lot. In the 21-trial review, a statistic that measures how much results vary across studies (called I2) was 90.2% for CRP. That is very high. It means the average hides big swings.
Second, the weakest studies told the best story. In the 2018 review, low-quality studies showed a CRP drop of 2.9 mg/L, bigger than the overall result. When weaker studies find bigger effects, the true effect is often smaller.
Third, the other markers wobble. One review of 12 studies found zinc lowered IL-6 but did not change TNF-alpha. The 21-trial review found the opposite: TNF-alpha went down, while IL-6 only "marginally" dropped.
Dose matters too. In the 2018 review, trials using 50 mg a day showed a larger CRP drop. That is a high dose, and high doses are where zinc's downside begins.
The copper problem
Zinc and copper compete. Too much zinc can block your body from taking in copper and iron, which can lead to copper deficiency and anemia (too few healthy red blood cells). Large amounts of zinc can also upset your cholesterol numbers and your immune system.
Copper deficiency is no small thing. It can affect how your bone marrow makes blood cells, and it can harm the nervous system. Blood problems usually recover with copper over 4 to 12 weeks. Nerve damage may only partly recover.
Zinc pills can also get in the way of some medicines. They may lower how well your body absorbs the antibiotics ciprofloxacin and doxycycline, and the bone drug risedronate.
What this means for you
Tick what you'll try this week. Your picks stay on this device.
you have kidney disease or are on dialysis; you have diabetes; you take antibiotics such as ciprofloxacin or doxycycline, a bone drug such as risedronate, a diuretic, or an ARB blood pressure drug; or you have anemia, numbness or tingling, or have been told your copper is low.
One tap. Results appear once 50 readers have voted, and the count is always real.
The bottom line
Eight trials in 2018, then 21, then 35: each new review found zinc pills nudging CRP down. But look closer and the trials were small and uneven, and many were in people on dialysis or living with diabetes. For them, zinc may help. For a healthy adult who already eats enough, the trials don't give an answer, and extra zinc has a real price in copper. Is zinc anti-inflammatory? For the right person, maybe. Find out if you are that person before you reach for the bottle.
Common questions
Does zinc reduce inflammation in the body?
In trials, zinc supplements lowered CRP, a blood marker of inflammation. A meta-analysis of 21 randomized trials found lower CRP and TNF-alpha. A review of 35 trials found lower CRP and hs-CRP. Most of these trials were small and varied a lot, and many tested people with kidney disease or diabetes. Whether healthy people benefit is not clear.
Does zinc affect inflammation markers like IL-6?
The results are mixed. A review of 12 studies found zinc lowered IL-6 but did not change TNF-alpha. A review of 21 randomized trials found the opposite: TNF-alpha dropped, while the IL-6 drop was only marginal. CRP is the marker with the most consistent results across reviews.
Can zinc reduce inflammation in people with diabetes?
In a 2026 meta-analysis of 18 randomized trials with 1,023 people with diabetes or prediabetes, zinc lowered CRP. It also improved insulin resistance and lowered total cholesterol a little. But LDL cholesterol went up slightly, and the authors said the meaning of that is uncertain. Talk to your doctor before adding zinc to diabetes care.
Can too much zinc be harmful?
Yes. Too much zinc can block copper and iron, which can lead to copper deficiency and anemia. Copper deficiency can affect blood cells and the nervous system, and nerve damage may only partly recover. Zinc pills can also lower how well some antibiotics and a bone drug are absorbed.
Ask the Research Desk
Heard something about inflammation you want checked? The best questions become articles, credited by first name only if you say yes.
How this article was made
Researched and written from 10 peer-reviewed papers. Our automated check matched every claim against the exact words of its source, confirmed every paper exists in PubMed, and found none retracted. Checked October 30, 2026. Not individually reviewed by a doctor. Photos are illustrative; the people in them are not patients or readers.
Grades run Strong, Moderate, Emerging, Early and Not supported, and the grade decides the words we may use. How we grade evidence · Medical disclaimer
Sources
- Meta-analysisThe effect of zinc supplementation on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials.Mousavi SM, Djafarian K, Mojtahed A et al. Eur J Pharmacol, 2018.PubMedFull paper
- Meta-analysisThe Effects of Zinc Supplementation on C-Reactive Protein and Inflammatory Cytokines: A Meta-Analysis and Systematical Review.Ceylan MN, Akdas S, Yazihan N J Interferon Cytokine Res, 2021.PubMedFull paper
- Meta-analysisProfiling inflammatory cytokines following zinc supplementation: a systematic review and meta-analysis of controlled trials.Faghfouri AH, Baradaran B, Khabbazi A et al. Br J Nutr, 2021.PubMedFull paper
- Meta-analysisZinc supplementation is associated with a reduction in serum markers of inflammation and oxidative stress in adults: A systematic review and meta-analysis of randomized controlled trials.Hosseini R, Ferns GA, Sahebkar A et al. Cytokine, 2021.PubMedFull paper
- Meta-analysisZinc supplementation and immune factors in adults: a systematic review and meta-analysis of randomized clinical trials.Jafari A, Noormohammadi Z, Askari M et al. Crit Rev Food Sci Nutr, 2022.PubMedFull paper
- Meta-analysisZinc supplementation and cardiovascular disease risk factors: A GRADE-assessed systematic review and dose-response meta-analysis.Nazari M, Ashtary-Larky D, Nikbaf-Shandiz M et al. J Trace Elem Med Biol, 2023.PubMedFull paper
- Meta-analysisEffects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Loaiza-Giraldo JP, Amigo-Fierro F, Cancino-Castro CI et al. Endocrinol Diabetes Metab, 2026.PubMedFull paper
- Meta-analysisEffect of Zinc Supplementation on Maintenance Hemodialysis Patients: A Systematic Review and Meta-Analysis of 15 Randomized Controlled Trials.Wang LJ, Wang MQ, Hu R et al. Biomed Res Int, 2017.PubMedFull paper
- ReviewRole of zinc in health and disease.Stiles LI, Ferrao K, Mehta KJ Clin Exp Med, 2024.PubMedFull paper
- ReviewCopper deficiency anemia: review article.Myint ZW, Oo TH, Thein KZ et al. Ann Hematol, 2018.PubMedFull paper
